Skip to Content

Zipsor FDA Approval History

FDA Approved: Yes (First approved June 16, 2009)
Brand name: Zipsor
Generic name: diclofenac potassium
Dosage form: Capsules
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Pain

Zipsor is a rapid release diclofenac potassium formulation for the treatment of patients with mild to moderate acute pain.

Development Timeline for Zipsor

DateArticle
Jun 17, 2009ApprovalXanodyne Receives Approval From the U.S. Food and Drug Administration for Zipsor (diclofenac potassium) Liquid Filled Capsules
Jul 22, 2008Xanodyne Receives Approvable Letter From the FDA for Zipsor Capsules

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.